Jae U Jung Selected Research

RNA Virus Infections

1/2018	Correction: FAS-associated factor-1 positively regulates type I interferon response to RNA virus infection by targeting NLRX1.
5/2017	FAS-associated factor-1 positively regulates type I interferon response to RNA virus infection by targeting NLRX1.
2/2014	USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase.
4/2007	TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jae U Jung Research Topics

Disease

42	Infections 01/2022 - 05/2002
29	Virus Diseases (Viral Diseases) 01/2022 - 11/2004
26	Neoplasms (Cancer) 01/2020 - 04/2002
11	COVID-19 10/2022 - 01/2020
9	Kaposi Sarcoma (Kaposi's Sarcoma) 09/2014 - 05/2002
8	Carcinogenesis 01/2020 - 01/2007
7	Zika Virus Infection 01/2021 - 10/2017
6	Inflammation (Inflammations) 01/2022 - 07/2013
6	Primary Effusion Lymphoma 01/2020 - 11/2005
5	Severe Fever with Thrombocytopenia Syndrome 01/2020 - 01/2019
5	Bites and Stings (Sting) 01/2019 - 02/2014
4	RNA Virus Infections 01/2018 - 04/2007
4	Porcine Reproductive and Respiratory Syndrome (PRRS) 11/2016 - 03/2012
3	Microcephaly 09/2019 - 10/2017
3	Persistent Infection 01/2018 - 11/2002
3	Human Influenza (Influenza) 01/2017 - 04/2012
3	Lymphoma (Lymphomas) 11/2016 - 06/2004
2	Pneumonia (Pneumonitis) 01/2022 - 01/2016
2	Pregnancy Complications 11/2021 - 11/2017
2	Crohn Disease (Crohn's Disease) 11/2020 - 07/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2020 - 07/2020
2	Vesicular Stomatitis 10/2019 - 01/2017
2	Latent Infection 01/2014 - 01/2013
2	Prostatic Neoplasms (Prostate Cancer) 01/2011 - 01/2009
2	Acquired Immunodeficiency Syndrome (AIDS) 10/2009 - 05/2005
1	Coinfection 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Reinfection 12/2021
1	Bronchiolitis 01/2020
1	Severe Acute Respiratory Syndrome 01/2020
1	Tick-Borne Diseases (Tick-Borne Disease) 01/2020

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2002
24	Antiviral Agents (Antivirals)IBA 11/2021 - 11/2004
17	InterferonsIBA 11/2020 - 11/2004
14	CytokinesIBA 01/2022 - 05/2002
11	Interferon Type IIBA 10/2022 - 04/2007
11	VaccinesIBA 01/2021 - 10/2009
7	Pharmaceutical PreparationsIBA 11/2020 - 11/2009
6	viral interferon regulatory factorsIBA 01/2018 - 03/2006
6	Phosphotransferases (Kinase)IBA 09/2015 - 03/2006
5	Peptides (Polypeptides)IBA 01/2019 - 11/2009
5	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 03/2006
4	Neutralizing AntibodiesIBA 01/2022 - 01/2021
4	RNA (Ribonucleic Acid)IBA 01/2021 - 07/2020
4	Viral RNAIBA 01/2020 - 04/2007
4	Ligases (Synthetase)IBA 10/2019 - 02/2014
4	Pattern Recognition ReceptorsIBA 11/2016 - 03/2012
4	Beclin-1IBA 02/2014 - 07/2006
3	ChemokinesIBA 01/2022 - 11/2018
3	Amino Acids FDA Link 01/2020 - 01/2017
3	NucleotidesIBA 10/2019 - 01/2017
3	UbiquitinIBA 10/2019 - 11/2015
3	EnzymesIBA 01/2019 - 01/2009
3	ChromatinIBA 01/2016 - 01/2013
3	cyclic guanosine monophosphate-adenosine monophosphateIBA 10/2015 - 02/2014
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2015 - 11/2012
3	Biological ProductsIBA 11/2012 - 10/2009
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2016
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2020 - 07/2009
2	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 03/2007
2	NitrogenIBA 01/2019 - 01/2017
2	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 01/2019 - 01/2009
2	Viral ProteinsIBA 01/2019 - 10/2013
2	A-Form DNA (A-DNA)IBA 01/2019 - 03/2006
2	AntigensIBA 01/2019 - 01/2017
2	Glutamine (L-Glutamine)FDA Link 01/2019 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2017
2	CaspasesIBA 01/2019 - 01/2009
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019 - 04/2007
2	Tripartite Motif ProteinsIBA 01/2019 - 10/2008
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2016 - 03/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 03/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2012 - 03/2008
2	Tetracycline (Achromycin)FDA LinkGeneric 11/2005 - 04/2003
1	Interleukin-17 ReceptorsIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Toll-Like Receptor 7IBA 01/2021
1	FurinIBA 01/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	MelatoninIBA 11/2020
1	Tenofovir (Viread)FDA Link 01/2020
1	Emtricitabine (Emtriva)FDA Link 01/2020
1	Azathioprine (Imuran)FDA LinkGeneric 01/2020
1	delta-1-pyrroline-5-carboxylateIBA 01/2020
1	Caveolin 1IBA 01/2020
1	Lopinavir FDA Link 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	AntioxidantsIBA 01/2020
1	Viral AntigensIBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	delta-1-Pyrroline-5-Carboxylate ReductaseIBA 01/2020
1	Enhancer RNAsIBA 01/2020
1	Proline (L-Proline)FDA Link 01/2020
1	Ritonavir (Norvir)FDA Link 01/2020
1	Attenuated VaccinesIBA 12/2019
1	Azithromycin (Zithromax)FDA LinkGeneric 09/2019

Therapy/Procedure

11	Therapeutics 11/2020 - 01/2009